G

Generate Biomedicines Inc
D

GENB

12.790
USD
-0.31
(-2.37%)
قبل الجلسة·12.900USD+0.110(+0.86%)
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
47,283
الربح لكل سهم
-3
العائد الربحي
-
P/E
-6
حجم السوق
1,641,627,656

العنوان: Generate Biomedicines Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology byusing machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.